4//SEC Filing
Graf James A 4
Accession 0001213900-24-107605
CIK 0001845459other
Filed
Dec 9, 7:00 PM ET
Accepted
Dec 10, 9:55 PM ET
Size
5.7 KB
Accession
0001213900-24-107605
Insider Transaction Report
Form 4
Graf James A
Chief Executive Officer10% Owner
Transactions
- Award
Stock Option (right to buy)
2024-12-06+500,000→ 500,000 totalExercise: $0.44Exp: 2034-12-06→ Common Stock (500,000 underlying)
Footnotes (1)
- [F1]On December 6, 2024, the Reporting Person was granted 500,000 options pursuant to the Company's 2023 Equity Incentive Plan, with 25% vesting immediately as of the grant date, and the remaining options vesting in 36 equal installments on the sixth of each month, beginning January 6, 2025, and ending December 6, 2027, subject to the Reporting Person's continued service with the Issuer on each respective vesting date.
Documents
Issuer
NKGen Biotech, Inc.
CIK 0001845459
Entity typeother
Related Parties
1- filerCIK 0001519672
Filing Metadata
- Form type
- 4
- Filed
- Dec 9, 7:00 PM ET
- Accepted
- Dec 10, 9:55 PM ET
- Size
- 5.7 KB